Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Young Adults Not Drinking Enough Milk
Calcium and dairy products play major roles in health maintenance and the prevention of chronic disease. Because peak bone mass is not achieved until the third decade of life, it is particularly important for young adults to consume adequate amounts of calcium, protein and vitamin D found in dairy products to support health and prevent osteoporosis later in life. In a study in the July/August issue of the Journal of Nutrition Education and Behavior, researchers report that young people actually reduce their intake of calcium and dairy products as they enter their twenties.
generic viagra online
Key To Potential New Treatment For Allergy-Induced Asthma Identified By Yale Team
In research that could lead to new asthma drugs, scientists at Yale School of Medicine, Hydra Biosciences of Cambridge, Massachusetts, and the University of California, San Francisco have discovered that a protein may be a trigger of allergy-induced asthma in mice. They also demonstrated how a drug known to reduce inflammatory and neuropathic pain may also inhibit asthma symptoms in mice. Their paper is published in the May 18-22 online Early Edition of the Proceedings of the National Academy of Sciences.
News of the day
Supermarket Discounts Promote Unhealthy Choices
Supermarket shoppers may be encouraged to buy sugar-filled, calorie-rich drinks by discounts and promotions, according to New Zealand research.
Public Health

Clinipace To Manage Two Phase II Clinical Trials For Inspire Pharmaceuticals

Clinipace, a digital clinical research organization, announced that Inspire Pharmaceuticals, Inc. has selected the company to manage and deploy two phase II studies for the ophthalmic prescription medicine, AzaSite®. Currently approved by the U.S. Food and Drug Administration (FDA) for the treatment of bacterial conjunctivitis, Inspire has initiated two Phase II randomized placebo-controlled clinical trials of AzaSite as a potential treatment of blepharitis, an ocular disease characterized by the inflammation of the eyelids. Clinipace will provide technology-driven clinical trial services to Inspire including data management (EDC), clinical monitoring, site management, regulatory document management, and biostatistical consulting. To bring increased trial visibility, the project team will utilize TEMPOTM for Clinical Trials software from Clinipace to manage site initiation, patient enrollment and randomization, clinical data capture, monitoring trip reports, site management, regulatory document tracking, and much more. "We share a common goal with Clinipace of changing the way we approach the clinical development process - shifting away from some of the more traditional CRO processes and moving towards an integrated technology-driven model," said Chad Ice, senior director, clinical research, Inspire. "With Clinipace, we plan to remove unnecessary layers of management and processes," said Ice. "We believe that Clinipace can help assure that communication with our clinical sites is much more seamless - one of the most vital links driving the success of our clinical trial process." "We"re hearing from the market time and time again that pharmaceutical companies are tired of having over-scaled and over-priced res pitched to them from CROs today," said Christopher Porter, chief operating officer, Clinipace. "That"s the driving force behind our dedication to providing innovative companies like Inspire a scalable solution with the right kind and quantity of res to match any size clinical study and operational approach." Clinipace


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009